Drugs & Therapy Perspectives

, Volume 18, Issue 6, pp 23–25 | Cite as

First reports of adverse drug reactions (ADRs) in recent weeks

Drug Reactions and Interactions


Lansoprazole Mirtazapine Rabeprazole Zonisamide Amisulpride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Pedrosa Gil F, Grohmann R, Rüther E. Asymptomatic bradycardia associated with amisulpride. Pharmacopsychiatry 2001 Nov; 34: 259–61PubMedCrossRefGoogle Scholar
  2. Kerrison JB, Lounsbury D, Thirkill CE, et al. Optic neuritis after anthrax vaccination. Ophthalmology 2002 Jan; 109: 99–104PubMedCrossRefGoogle Scholar
  3. Clark SJ, Creighton S, Portmann B, et al. Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol 2002 Feb; 36: 295–301PubMedCrossRefGoogle Scholar
  4. Flores-Suárez LF, Morales H, Angeles A, et al. Drug-induced amyopathic dermatomyositis. J Clin Rheumatol 2002 Feb; 8: 50–4PubMedCrossRefGoogle Scholar
  5. Cohen LM, Ugent RB. Linear IgA bullous dermatosis occurring after carbamazepine. J Am Acad Dermatol 2002 Feb; 46 (Suppl.): 32–3CrossRefGoogle Scholar
  6. Giner V, Muñoz R, Redón J. Risperidone and severe cerivastatin-induced rhabdomyolysis. J Intern Med 2002 Feb; 251: 177–8PubMedCrossRefGoogle Scholar
  7. Masiá M, Gutiérrez F, Jimeno A, et al. Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy. Arch Intern Med 2002 Feb; 162: 474–6PubMedCrossRefGoogle Scholar
  8. Prior FH, Isbister GK, Dawson AH, et al. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine. Med J Aust 2002 Mar; 176: 240–1PubMedGoogle Scholar
  9. Payá B, Guisado JA, Vaz FJ, et al. Visual hallucinations induced by the combination of prolintane and diphenhydramine. Pharmacopsychiatry 2002 Jan; 35: 24–5PubMedCrossRefGoogle Scholar
  10. Goland S, Kazarsky R, Kagan A, et al. Renal vasculitis associated with doxycycline. J Pharm Technol 2001 Sep–Oct; 17: 220–2Google Scholar
  11. Gulbranson SH, Mock RE, Wolfrey JD. Possible ergotamine-caffeine-associated delirium. Pharmacotherapy 2002 Jan; 22: 126–9PubMedCrossRefGoogle Scholar
  12. Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 2001 Nov; 57: 1885–8PubMedCrossRefGoogle Scholar
  13. Ng B. Mania associated with mirtazapine augmentation of fluoxetine. Depress Anxiety 2002; 15(1): 46–7PubMedCrossRefGoogle Scholar
  14. Reeves S, Howard R. Depot injections and nut allergy. Br J Psychiatry 2002 Feb; 180: 188PubMedCrossRefGoogle Scholar
  15. Laack E, Mende T, Knuffmann C, Hossfeld DK. Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine. Ann Oncol 2001 Dec; 12: 1761–3PubMedCrossRefGoogle Scholar
  16. Au S, Tullis GD, Crawford RI. Linear IgA bullous dermatosis associated with ibuprofen therapy. 60th Annual Meeting of the American Academy of Dermatology 2002 Feb: 124Google Scholar
  17. Raanani P, Goldman JM, Ben-Bassat I. Depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol 2002 Feb; 20: 869–70PubMedGoogle Scholar
  18. Dann EJ, Fineman R, Rowe JM. Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia. J Clin Oncol 2002 Jan; 20: 354–5PubMedGoogle Scholar
  19. Begovac J, Krpan D, Kusec V. Bony exostoses and osteosclerosis in an HIV-infected patient treated with indinavir. 8th European Conference on Clinical Aspects and Treatment of HIV-Infection 2001 Oct: 112Google Scholar
  20. McCain ME, Quinet RJ, Davis WE. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology 2002 Jan; 41: 116–7PubMedCrossRefGoogle Scholar
  21. Chan ATY, Cleeve V, Daymond TJ. Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J 2002 Jan; 78: 47–8PubMedCrossRefGoogle Scholar
  22. Mandrup-Poulsen T, Mølvig J, Pildal J, et al. Leukocytoclastic vasculitis induced by subcutaneous injection of human insulin in a patient with type 1 diabetes and essential thrombocytemia. Diabetes Care 2002 Jan; 25: 242–3PubMedCrossRefGoogle Scholar
  23. Thomas R, Stea B. Radiation recall dermatitis from high-dose interferon alfa-2b. J Clin Oncol 2002 Jan; 20: 355–7PubMedCrossRefGoogle Scholar
  24. Hernández-Núñez A, Riuz-Genao DP, Ríos-Buceta L, et al. Interferon alfa-2b induced livedo reticularis. Report of two cases. 60th Annual Meeting of the American Academy of Dermatology 2002 Feb; 158Google Scholar
  25. Heinzerling L, Dummer R, Burg G, et al. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol 2002 Mar–Apr; 12: 194–7PubMedGoogle Scholar
  26. Mathijssen RHJ, Sparreboom A, Dumez H, et al. Altered irinotecan metabolism in a patient receiving phenytoin. Anticancer Drugs 2002 Feb; 13: 139–40PubMedCrossRefGoogle Scholar
  27. Koenig AS, Abruzzo JL. Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis. J Rheumatol 2002 Jan; 29: 192–4PubMedGoogle Scholar
  28. Enzenauer RJ, Khan KJ. Pneumocystis carinii pneumonia associated with leflunomide therapy for rheumatoid arthritis. J Clin Rheumatol 2002 Feb; 8: 64–5PubMedCrossRefGoogle Scholar
  29. Kossoff EH, Bergey GK, Freeman JM, et al. Levetiracetam psychosis in children with epilepsy. Epilepsia 2001 Dec; 42: 1611–3PubMedCrossRefGoogle Scholar
  30. Bomann JS, Peckler BF. Type IV renal tubular acidosis presenting as dyspnea in two older patients taking angiotensin-converting enzyme inhibitors. Ann Emerg Med 2002 Jan; 39: 73–6PubMedCrossRefGoogle Scholar
  31. Thami GP, Kaur S, Kanwar AJ. Delayed reactivation of haloperidol induced photosensitive dermatitis by methotrexate. Postgrad Med J 2002 Feb; 78: 116–7PubMedCrossRefGoogle Scholar
  32. Fernández-Espartero MC, Rodríguez M, de la Mata J. Methotrexate-induced nephrogenic diabetes insipidus: first case report. Rheumatology 2002 Feb; 41: 233–4PubMedCrossRefGoogle Scholar
  33. Jolliet P, Veyrac G, Bourin M. First report of mirtazapine-induced arthralgia. Eur Psychiatry 2001 Dec; 16: 503–5PubMedCrossRefGoogle Scholar
  34. Wise MEJ, Mistry K, Reid S. Neuropsychiatric complications of nevirapine treatment. BMJ 2002 Apr; 324: 879PubMedCrossRefGoogle Scholar
  35. Yasui-Furukori N, Tateishi T. Carbamazepine decreases antihypertensive effect of nilvadipine. J Clin Pharmacol 2002 Jan; 42: 100–3PubMedCrossRefGoogle Scholar
  36. Preston IR, Klinger JR, Houtchens J, et al. Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome. Chest 2002 Feb; 121: 656–9PubMedCrossRefGoogle Scholar
  37. Schiff JD, Ziecheck WS, Choi B. Pulmonary embolus related to PC-SPES use in a patient with PSA recurrence after radical prostatectomy. Urology 2002 Mar; 59: 444PubMedCrossRefGoogle Scholar
  38. Tabamo RE, Di Rocco A. Alopecia induced by dopamine agonists. Neurology 2002 Mar; 58: 829–30PubMedCrossRefGoogle Scholar
  39. Hedges DW, Jeppson KG. New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother 2002 Mar; 36: 437–9PubMedCrossRefGoogle Scholar
  40. Voog E, Brice P, Cartron J, et al. Acute agranulocytosis in three patients treated with rituximab for non Hodgkin lymphoma. Blood 2001 Nov; 98(Pt. 2): 236Google Scholar
  41. Mehta AC, Mtanos GJ, Gentile TC. Exacerbation of lupus while receiving rituximab for chronic refractory thrombocytopenia. Blood 2001 Nov; 98(Pt. 2): 61–2Google Scholar
  42. Bonnel RA, Villalba ML, Karwoski CB, et al. Aseptic meningitis associated with rofecoxib. Arch Intern Med 2002 Mar; 162: 713–5PubMedCrossRefGoogle Scholar
  43. McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol 2002 Mar; 25: 133–4PubMedCrossRefGoogle Scholar
  44. Homma M, Itagaki F, Yuzawa K, et al. Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. Transplantation 2002 Jan; 73: 303–4PubMedCrossRefGoogle Scholar
  45. Marini M, Wright D, Ropolo M, et al. Neutrophilic eccrine hidradenitis secondary to topotecan. J Dermatolog Treat 2002 Mar; 13: 35–7PubMedCrossRefGoogle Scholar
  46. Asai S, Miyachi H, Kobayashi H, et al. Smoldering myeloma associated with zonisamide treatment. Intern Med 2002 Feb; 41: 138–41PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Personalised recommendations